Results 11 to 20 of about 30,350 (261)
Biotechnology Journal, 2006 AbstractThe biopharmaceutical industry, whose products are produced mainly by recombinant DNA technology, antibody technologies and cytotechnology, is the most important sector in industrial biotechnology, and is one of the most rapidly growing high‐tech industries.
Xianwen, Hu, Qingjun, Ma, Shuyong, Zhang
openaire +3 more sources
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
Antibodies, 2019 The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various ...
Felix Kuhne +9 more
doaj +1 more source
Separations, 2018 Antibody-drug conjugates (ADCs) are promising state-of-the-art biopharmaceutical drugs for selective drug-delivery applications and the treatment of diseases such as cancer.
Filip S. Ekholm +8 more
doaj +1 more source
A study on the Development of Biopharmaceutical Companies Based on the Context of Big Data [PDF]
BIO Web of Conferences, 2023 Based on the requirements of the computer technology background in the new era, this paper takes Chinese biopharmaceutical enterprises as the research object, outlines the general characteristics of innovation in Chinese biopharmaceutical enterprises ...
Li Weichao
doaj +1 more source
Microbiology Spectrum, 2014 ABSTRACTPlasmids are currently an indispensable molecular tool in life science research and a central asset for the modern biotechnology industry, supporting its mission to produce pharmaceutical proteins, antibodies, vaccines, industrial enzymes, and molecular diagnostics, to name a few key products.
Duarte Miguel F, Prazeres +1 more
openaire +2 more sources
Human Vaccines & Immunotherapeutics, 2020 “Values-based decision-making” frameworks and models are widely described in the literature in various disciplines, including healthcare settings.
Tatjana Poplazarova +2 more
doaj +1 more source
Florea: Jurnal Biologi dan Pembelajarannya, 2022 The diversity of Biopharmaca plant species in the Kalibakung Jamu Health Tourism area has not been fully utilized by the surrounding community, the community is only familiar with a few plants which makes this one of the factors not utilizing plants in ...
Salsabila Zahirotul Maghfiroh +2 more
doaj +1 more source
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D
mAbs, 2020 This study aims to benchmark and analyze the process development and manufacturing costs across the biopharmaceutical drug development cycle and their contribution to overall research and development (R&D) costs.
Suzanne S. Farid +4 more
doaj +1 more source
Life, 2021 Biopharmaceutical production is currently a multibillion-dollar industry with high growth perspectives. The research and development of biologically sourced pharmaceuticals are extremely important and a reality in our current healthcare system ...
Felipe Grabarz +9 more
doaj +1 more source
Academic, Сommercialization and Societal Effects of Joint Research
Foresight and STI Governance, 2022 The work investigates the effects that a specific science industry collaboration scheme, joint research, generates in three areas, such as: production of academic activities, scientific knowledge commercialization and society at large. It is an in-depth
Vladimiro Verre +2 more
doaj +1 more source